We believe artificial intelligence (AI) will be an inevitable part of health care in the future, and this week we’ve taken steps to partner with our new Boston neighbor, GE Healthcare, to ensure that we remain at the forefront of discovery and innovation in this space.
Together we’re embarking on a 10-year collaboration to develop and integrate AI and “deep learning” technology across the entire continuum of patient care. This strategic partnership will be based in the newly formed Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science. At the center, multidisciplinary teams will have broad access to data, computational infrastructure and clinical expertise. They’ll use this access to develop applications aimed at improving clinician productivity and patient outcomes in diagnostic imaging.
Over time, the center will develop new business models and products for medical specialties, such as molecular pathology, genomics and population health.
Together, we can empower clinicians with the tools needed to store, analyze and leverage the flood of information to more effectively deliver care to patients.David Torchiana, MD, CEO of Partners HealthCare
For David Torchiana, MD, CEO of Partners HealthCare, the GE Healthcare partnership represents a tangible moment of change for medicine.
“Clinicians are inundated with data, and the patient experience suffers from inefficiencies in the healthcare industry. By combining the expertise at Mass General and Brigham and Women’s with the spirit of innovation at GE, this partnership has the resources and vision to accelerate the development and adoption of deep learning technology,” he said. “Together, we can empower clinicians with the tools needed to store, analyze and leverage the flood of information to more effectively deliver care to patients.”
Ultimately, we believe that AI will allow the medical community to implement AI and machine learning technologies into every step of the patient journey.
And once these AI applications are developed and deployed, clinicians and patients will benefit from a variety of tools that span disease areas, diagnostic modalities and treatment strategies and have the potential to do everything from decrease unnecessary biopsies to streamline clinical workflows to increase the amount of time clinicians spend with patients versus performing administrative tasks.